MK-677 for Wound Healing
Research, mechanism, dosing, and effectiveness of MK-677 for wound healing.
Quick Answer
GH elevation accelerates wound healing.
Evidence Level
Human Trials
Typical Dose
15-25 mg daily
Results Timeline
Wound healing within 2-4 weeks
FDA Status
Research Only
How MK-677 Works for Wound Healing
Growth hormone promotes tissue repair.
About Wound Healing
Acceleration of wound closure, skin repair, and tissue regeneration.
Research Evidence
Studies show increases in GH and IGF-1 levels, improved sleep quality, and increased lean body mass. However, a clinical trial was stopped early due to heart failure concerns in elderly patients. FDA lists MK-677 as having 'significant safety risks due to potential for congestive heart failure.' December 2025: FDA issued warning letters to companies selling MK-677. Never received FDA approval and remains an unapproved drug.
Dosing for Wound Healing
Recommended Dose
15-25 mg daily
Frequency
Once daily, often before bed
Administration
Oral
Duration
8-12 weeks or longer
Note: Oral GH secretagogue. Can cause water retention, increased appetite, and blood sugar issues. Some cycle it, others run year-round.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Increased appetite and hunger
- •Weight gain
- •Water retention/edema
- •Insulin resistance
- •Elevated blood glucose/hyperglycemia
- •Anxiety
Frequently Asked Questions
Does MK-677 help with wound healing?
GH elevation accelerates wound healing.
How does MK-677 work for wound healing?
Growth hormone promotes tissue repair....
What dose of MK-677 should I use for wound healing?
15-25 mg daily
How long until I see results?
Wound healing within 2-4 weeks
Other Peptides for Wound Healing
These peptides are also researched for wound healing.
Ipamorelin
Clinical TrialsA selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin. Considered one of the safest GHRPs.
CJC-1295 (No DAC)
Clinical TrialsA synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates GH release from the pituitary. Often combined with a GHRP like Ipamorelin for synergistic effects.
Tesamorelin
FDAAn FDA-approved GHRH analog used to reduce excess abdominal fat in HIV-infected patients with lipodystrophy. New F8 formulation (Egrifta WR) approved March 2025 allows weekly reconstitution vs daily.
GHRP-6
Clinical TrialsOne of the first synthetic GH secretagogues developed. Strongly stimulates GH release and significantly increases appetite through ghrelin receptor activation.